213 related articles for article (PubMed ID: 8815460)
1. [Mechanisms involved in the prolonged humoral immune response: behavior of aphthous fever virus].
Wigdorovitz A; Sadir A
Rev Argent Microbiol; 1996; 28(1):45-54. PubMed ID: 8815460
[TBL] [Abstract][Full Text] [Related]
2. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
[TBL] [Abstract][Full Text] [Related]
3. The relationship between cellular immune response to foot-and-mouth disease virus Asia 1 and viral persistence in Indian cattle (Bosindicus).
Maddur MS; Kishore S; Chockalingam AK; Gopalakrishna S; Singh N; Suryanarayana VV; Gajendragad MR
Res Vet Sci; 2010 Aug; 89(1):36-40. PubMed ID: 20189208
[TBL] [Abstract][Full Text] [Related]
4. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
6. [Humoral immune response in cattle vaccinated against aphthovirus. Study of the kinetics of protective and neutralizing antibodies].
Rojas GB; Rottenberg ME; Brunengo AM
Rev Argent Microbiol; 1984; 16(4):195-208. PubMed ID: 6101040
[TBL] [Abstract][Full Text] [Related]
7. Serotype-independent detection of foot-and-mouth disease virus.
Muller JD; McEachern JA; Bossart KN; Hansson E; Yu M; Clavijo A; Hammond JM; Wang LF
J Virol Methods; 2008 Jul; 151(1):146-53. PubMed ID: 18440078
[TBL] [Abstract][Full Text] [Related]
8. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
9. [Immune response against foot-and-mouth disease virus in cattle: effect of vaccination].
Braun M; Sigal L; Mundo S; Ramayo L; Jar AM; Gómez G; Fontanals A; Mazzuca GO
Medicina (B Aires); 1989; 49(3):216-20. PubMed ID: 2562135
[TBL] [Abstract][Full Text] [Related]
10. Synthetic peptide vaccines: foot-and-mouth disease virus as a model.
Sobrino F; Blanco E; García-Briones M; Ley V
Dev Biol Stand; 1999; 101():39-43. PubMed ID: 10566773
[TBL] [Abstract][Full Text] [Related]
11. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. II. Stability problems].
Ackermann M; Müller HK; Bruckner L; Kihm U
Schweiz Arch Tierheilkd; 1989; 131(7):389-95. PubMed ID: 2552580
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant effect of Cliptox on the protective immune response induced by an inactivated vaccine against foot and mouth disease virus in mice.
Batista A; Quattrocchi V; Olivera V; Langellotti C; Pappalardo JS; Di Giacomo S; Mongini C; Portuondo D; Zamorano P
Vaccine; 2010 Aug; 28(38):6361-6. PubMed ID: 20637310
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
[TBL] [Abstract][Full Text] [Related]
14. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
Niedbalski W
Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate.
Mason PW; Piccone ME; Mckenna TS; Chinsangaram J; Grubman MJ
Virology; 1997 Jan; 227(1):96-102. PubMed ID: 9007062
[TBL] [Abstract][Full Text] [Related]
17. The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes.
Ostrowski M; Vermeulen M; Zabal O; Zamorano PI; Sadir AM; Geffner JR; Lopez OJ
J Virol; 2007 Sep; 81(17):9357-67. PubMed ID: 17567692
[TBL] [Abstract][Full Text] [Related]
18. Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle.
McKercher PD; Moore DM; Morgan DO; Robertson BH; Callis JJ; Kleid DG; Shire SJ; Yansura DG; Dowbenko D; Small B
Am J Vet Res; 1985 Mar; 46(3):587-90. PubMed ID: 2986495
[TBL] [Abstract][Full Text] [Related]
19. The carrier state in foot and mouth disease--an immunological review.
Salt JS
Br Vet J; 1993; 149(3):207-23. PubMed ID: 8392891
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and functional characterization of T-cells and in vitro replication of FMDV serotypes in bovine lymphocytes.
Joshi G; Sharma R; Kakker NK
Vaccine; 2009 Nov; 27(48):6656-61. PubMed ID: 19751690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
